EverSource Wealth Advisors LLC Grows Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

EverSource Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 16.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,210 shares of the medical equipment provider’s stock after purchasing an additional 170 shares during the period. EverSource Wealth Advisors LLC’s holdings in Intuitive Surgical were worth $632,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of ISRG. Berbice Capital Management LLC purchased a new position in Intuitive Surgical during the fourth quarter valued at $26,000. BankPlus Trust Department purchased a new position in Intuitive Surgical during the fourth quarter valued at $28,000. Kohmann Bosshard Financial Services LLC purchased a new position in Intuitive Surgical during the fourth quarter valued at $31,000. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical during the third quarter valued at $33,000. Finally, Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical during the fourth quarter valued at about $36,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Mark Brosius sold 489 shares of the business’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $533.18, for a total transaction of $260,725.02. Following the completion of the transaction, the senior vice president now owns 2,091 shares in the company, valued at $1,114,879.38. The trade was a 18.95 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Brian Edward Miller sold 8,900 shares of the business’s stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the transaction, the executive vice president now owns 5,758 shares of the company’s stock, valued at $2,793,033.06. This trade represents a 60.72 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 22,209 shares of company stock worth $11,928,127. Corporate insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have commented on ISRG. Wells Fargo & Company raised their price target on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Raymond James raised their price target on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Piper Sandler reissued an “overweight” rating and set a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Finally, Citigroup raised their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Trading Down 4.1 %

ISRG opened at $476.78 on Friday. The firm has a market cap of $169.82 billion, a P/E ratio of 74.38, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock has a 50-day moving average of $568.47 and a 200 day moving average of $531.22.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.